OBJECTIVE: Our understanding of optimum health care delivery for cancer survivors is limited by the lack of a patient-centred perspective. The objectives of the present study were to explore the views of breast and colorectal cancer survivors on their routine follow-up care, with respect to needs, preferences, and quality of follow-up, and their views on cancer specialist- compared with family physician (fp)-led follow-up care. METHODS: In Nova Scotia, Canada, 23 cancer survivors (13 breast, 10 colorectal) participated in either a focus group or a one-on-one interview. Participants were asked to reflect upon their lives as cancer survivors and on the type and quality of care and support they received during the follow-up period. Each focus group or interview was transcribed verbatim, and the transcripts were audited and subjected to a thematic analysis. RESULTS: SIX THEMES WERE IDENTIFIED: My care is my responsibilityHow I receive information on follow-up careI have many care needsI want to be prepared and informedThe role of my fp in my cancer experience and follow-up careThe role of media Survivors often characterized the post-primary treatment experience as lacking in information and preparation for follow-up and providing inadequate support to address many of the care needs prevalent in survivor populations. Despite valuing fp participation in follow-up care, many survivors continued to receive comfort and reassurance from specialist care. CONCLUSIONS: Our findings point to the need to implement strategies that better prepare breast cancer and colorectal cancer survivors for post-treatment care and that reassure survivors of the ability of their fp to provide quality care during this period.
OBJECTIVE: Our understanding of optimum health care delivery for cancer survivors is limited by the lack of a patient-centred perspective. The objectives of the present study were to explore the views of breast and colorectal cancer survivors on their routine follow-up care, with respect to needs, preferences, and quality of follow-up, and their views on cancer specialist- compared with family physician (fp)-led follow-up care. METHODS: In Nova Scotia, Canada, 23 cancer survivors (13 breast, 10 colorectal) participated in either a focus group or a one-on-one interview. Participants were asked to reflect upon their lives as cancer survivors and on the type and quality of care and support they received during the follow-up period. Each focus group or interview was transcribed verbatim, and the transcripts were audited and subjected to a thematic analysis. RESULTS: SIX THEMES WERE IDENTIFIED: My care is my responsibilityHow I receive information on follow-up careI have many care needsI want to be prepared and informedThe role of my fp in my cancer experience and follow-up careThe role of media Survivors often characterized the post-primary treatment experience as lacking in information and preparation for follow-up and providing inadequate support to address many of the care needs prevalent in survivor populations. Despite valuing fp participation in follow-up care, many survivors continued to receive comfort and reassurance from specialist care. CONCLUSIONS: Our findings point to the need to implement strategies that better prepare breast cancer and colorectal cancer survivors for post-treatment care and that reassure survivors of the ability of their fp to provide quality care during this period.
Entities:
Keywords:
Breast cancer; colorectal cancer; follow-up care; oncology; survivorship
Authors: Eva Grunfeld; Mark N Levine; Jim A Julian; Doug Coyle; Barbara Szechtman; Doug Mirsky; Shailendara Verma; Susan Dent; Carol Sawka; Kathleen I Pritchard; David Ginsburg; Marjorie Wood; Tim Whelan Journal: J Clin Oncol Date: 2006-01-17 Impact factor: 44.544
Authors: Eva Grunfeld; Jim A Julian; Gregory Pond; Elizabeth Maunsell; Douglas Coyle; Amy Folkes; Anil A Joy; Louise Provencher; Daniel Rayson; Dorianne E Rheaume; Geoffrey A Porter; Lawrence F Paszat; Kathleen I Pritchard; André Robidoux; Sally Smith; Jonathan Sussman; Susan Dent; Jeffrey Sisler; Jennifer Wiernikowski; Mark N Levine Journal: J Clin Oncol Date: 2011-10-31 Impact factor: 44.544
Authors: Aimee Kendall Roundtree; Sharon H Giordano; Andrea Price; Maria E Suarez-Almazor Journal: Support Care Cancer Date: 2010-12-09 Impact factor: 3.603
Authors: Patricia A Ganz; Lorna Kwan; Annette L Stanton; Janice L Krupnick; Julia H Rowland; Beth E Meyerowitz; Julienne E Bower; Thomas R Belin Journal: J Natl Cancer Inst Date: 2004-03-03 Impact factor: 13.506
Authors: D A Wattchow; D P Weller; A Esterman; L S Pilotto; K McGorm; Z Hammett; C Platell; C Silagy Journal: Br J Cancer Date: 2006-04-24 Impact factor: 7.640
Authors: Julia R Berian; Amanda Cuddy; Amanda B Francescatti; Linda O'Dwyer; Y Nancy You; Robert J Volk; George J Chang Journal: J Cancer Surviv Date: 2017-06-22 Impact factor: 4.442
Authors: C Kendell; K M Decker; P A Groome; M L McBride; L Jiang; M K Krzyzanowska; G Porter; D Turner; R Urquhart; M Winget; E Grunfeld Journal: Curr Oncol Date: 2017-04-27 Impact factor: 3.677
Authors: R Vera; J Aparicio; F Carballo; M Esteva; E González-Flores; J Santianes; F Santolaya; J M Fernández-Cebrián Journal: Clin Transl Oncol Date: 2019-02-14 Impact factor: 3.405
Authors: Lauren P Wallner; Yun Li; Allison K C Furgal; Christopher R Friese; Ann S Hamilton; Kevin C Ward; Reshma Jagsi; Steven J Katz; Sarah T Hawley Journal: J Clin Oncol Date: 2017-07-12 Impact factor: 50.717
Authors: Judith A Meiklejohn; Alexander Mimery; Jennifer H Martin; Ross Bailie; Gail Garvey; Euan T Walpole; Jon Adams; Daniel Williamson; Patricia C Valery Journal: J Cancer Surviv Date: 2016-05-02 Impact factor: 4.442
Authors: Lauren P Wallner; Paul Abrahamse; Jaspreet K Uppal; Christopher R Friese; Ann S Hamilton; Kevin C Ward; Steven J Katz; Sarah T Hawley Journal: J Clin Oncol Date: 2016-10-31 Impact factor: 50.717